原调节蛋白 3 过表达作为卵巢癌铂耐药和免疫浸润的标志物
Please note that all translations are automatically generated. Click here for the English version.
2.5K Views
•
09:40 min
•
August 2nd, 2024
DOI :
August 2nd, 2024
•Dingwen Xu*1, Xiaofei Hu*2, Yang Feng1, Zhihua Lu1, Xianmei Liu3, Huishen Yan1, Jianming Peng1, Sen Luo1, Weijuan Yao4
1Department of Clinic, School of Medicine, Yangzhou Polytechnic College, 2Department of Nuclear Medicine, Huangshi Central Hospital, Affiliated Hospital of Hubei Institute of Technology, 3School of Biology and Engineering, Guizhou Medical University, 4Hemorheology Center, Department of Physiology and Pathophysiology, School of Basic Medical Sciences, Peking University Health Science Center
副本
探索更多视频
此视频中的章节
0:00
Introduction
0:51
Analyzing the Expression of TMOD3 in Normal Ovarian Tissues and Ovarian Cancer
2:23
Assessing the Effect of TMOD3 on Overall Survival and Progression‐Free Survival (PFS) in Ovarian Cancer Patients
4:15
TMOD3 Expression Analysis in Platinum‐Based Chemotherapy Resistant and Sensitive Patients and mRNA‐miRNA Analysis
6:56
Checking the Distribution of TMOD3 in Immune Cells and TMOD3 Coexpression Networks in Ovarian Cancer
相关视频
10:35
浆液性卵巢癌原位模型在免疫小鼠，为在体内肿瘤显像和肿瘤免疫反应的监测
18.1K Views
07:54
在使用定量免疫肿瘤的异质性蛋白表达的映射
18.6K Views
12:42
异型三维
15.0K Views
09:08
生物信息学方法与实验验证的集成，了解诺奇信号在卵巢癌中的作用
6.6K Views
10:27
使用结构DNA改变分析和患者衍生异种移植测试癌症的靶向疗法
7.1K Views
05:44
分离近端液研究胰腺腺癌肿瘤微环境
3.3K Views
14:25
在实时的间皮细胞卵巢癌球体附件和入侵评估
17.3K Views
08:55
小鼠模型的非侵入性成像检测和监测卵巢癌复发
12.2K Views
07:47
TMEM200A作为泛癌生物标志物的多组学分析
1.4K Views
07:47
TMEM200A作为泛癌生物标志物的多组学分析
1.4K Views
版权所属 © 2025 MyJoVE 公司版权所有，本公司不涉及任何医疗业务和医疗服务。